Gregory T. Bramblett

Abnormal tau phosphorylation at Ser396 in alzheimer's disease recapitulates development and contributes to reduced microtubule binding

Gregory T. Bramblett, Michel Goedert, Ross Jakes et al. · Neuron · 1993 · 892 citations

Neurodegenerative Diseases, Signal Transduction, Alzheimer's Disease +12

Altered <i>Tau</i> and Neurofilament Proteins in Neuro‐Degenerative Diseases: Diagnostic Implications for Alzheimer's Disease and Lewy Body Dementias

John Q. Trojanowski, Marie L. Schmidt, Ryong‐Woon Shin et al. · Brain Pathology · 1993 · 216 citations · Full text

Immunosuppression‐induced leukoencephalopathy from tacrolimus (FK506)

Steven L. Small, Gregory T. Bramblett, Benjamin H. Eidelman et al. · Annals of Neurology · 1996 · 118 citations

Regions with abundant neurofibrillary pathology in human brain exhibit a selective reduction in levels of binding-competent tau and accumulation of abnormal tau-isoforms (A68 proteins).

Gregory T. Bramblett, John Q. Trojanowski, V. M.-Y. Lee · PubMed · 1992 · 115 citations

Calcium/phospholipid-dependent kinase recognizes sites in microtubule-associated protein 2 which are phosphorylated in living brain and are not accessible to other kinases.

Shingo Tsuyama, Gregory T. Bramblett, Kuo‐Ping Huang et al. · Journal of Biological Chemistry · 1986 · 96 citations · Full text